{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T13:22:27Z","timestamp":1788355347340,"version":"build-2803163510"},"reference-count":68,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.jtct.2022.03.027","type":"journal-article","created":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T01:43:52Z","timestamp":1649468632000},"page":"355.e1-355.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of Serum Insulin-Like Growth Factor 1 on Hematopoietic Stem Cell Transplantation Outcome in Pediatric Cancer Patients"],"prefix":"10.1016","volume":"28","author":[{"given":"Deborah","family":"Betzmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"D\u00f6ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0129-4827","authenticated-orcid":false,"given":"Gunnar","family":"Blumenstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike","family":"Erdmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desiree","family":"Grabow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7988-3587","authenticated-orcid":false,"given":"Gerhard","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2022.03.027_bib0001","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/bmt.2011.110","article-title":"The EBMT risk score","volume":"47","author":"Gratwohl","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.03.027_bib0002","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1002\/cncr.23375","article-title":"Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation","volume":"112","author":"Sorror","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.jtct.2022.03.027_bib0003","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.03.027_bib0004","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bbmt.2007.12.487","article-title":"Risk-adjusted outcome measurement in pediatric allogeneic stem cell transplantation","volume":"14","author":"Matthes-Martin","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.03.027_bib0005","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1182\/blood-2018-02-791509","article-title":"Biomarkers for posttransplantation outcomes","volume":"131","author":"Paczesny","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.03.027_bib0006","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cll.2018.10.005","article-title":"Biomarkers for early complications after hematopoietic stem cell transplantation","volume":"39","author":"Rowan","year":"2019","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.jtct.2022.03.027_bib0007","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/(SICI)1099-0895(199610)12:3<195::AID-DMR164>3.0.CO;2-G","article-title":"Insulin-like growth factor I: physiology, metabolic effects and clinical uses","volume":"12","author":"Froesch","year":"1996","journal-title":"Diabetes Metab Rev"},{"key":"10.1016\/j.jtct.2022.03.027_bib0008","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1146\/annurev.ph.55.030193.001023","article-title":"The insulin-like growth factors","volume":"55","author":"Cohick","year":"1993","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.jtct.2022.03.027_bib0009","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ecl.2012.04.017","article-title":"Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes","volume":"41","author":"Clemmons","year":"2012","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.jtct.2022.03.027_bib0010","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1651-2227.1998.tb01386.x","article-title":"Changes in protein turnover, IGF-I and IGF binding proteins in children with cancer","volume":"87","author":"Attard-Montalto","year":"1998","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jtct.2022.03.027_bib0011","first-page":"597","article-title":"Nonparallel changes of growth hormone (GH) and insulin-like growth factor-I, insulin-like growth factor binding protein-3, and GH-binding protein, after craniospinal irradiation and chemotherapy","volume":"78","author":"Nivot","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jtct.2022.03.027_bib0012","first-page":"3121","article-title":"Effects of intensive chemotherapy on bone and collagen turnover and the growth hormone axis in children with acute lymphoblastic leukemia","volume":"83","author":"Crofton","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jtct.2022.03.027_bib0013","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.breast.2005.04.009","article-title":"Serum levels of IGF-1 and IGFBP-3 during adjuvant chemotherapy for primary breast cancer","volume":"15","author":"F\u00fcrstenberger","year":"2006","journal-title":"Breast"},{"key":"10.1016\/j.jtct.2022.03.027_bib0014","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1038\/bjc.1998.274","article-title":"Plasma insulin-like growth factor in primary breast cancer patients treated with adjuvant chemotherapy","volume":"77","author":"Peyrat","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtct.2022.03.027_bib0015","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1096-6374(98)80298-0","article-title":"Thrity-day monitoring of insulin-like growth factors and their binding proteins in intensive care unit patients","volume":"8","author":"Baxter","year":"1998","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.jtct.2022.03.027_bib0016","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/00003246-198708000-00004","article-title":"Relationship of somatomedin-C\/insulin-like growth factor I levels to conventional nutritional indices in critically ill patients","volume":"15","author":"Hawker","year":"1987","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jtct.2022.03.027_bib0017","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1056\/NEJM199909093411102","article-title":"Increased mortality associated with growth hormone treatment in critically ill adults","volume":"341","author":"Takala","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2022.03.027_bib0018","first-page":"309","article-title":"Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues","volume":"83","author":"Van den Berghe","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jtct.2022.03.027_bib0019","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF03350325","article-title":"Low IGF-I levels are often uncoupled with elevated GH levels in catabolic conditions","volume":"21","author":"Gianotti","year":"1998","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.jtct.2022.03.027_bib0020","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2265.1991.tb03495.x","article-title":"Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I","volume":"35","author":"Ross","year":"1991","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jtct.2022.03.027_bib0021","series-title":"107th Congress of the German Society for Surgery. April 17-21, 1990; Berlin. Vol. 266","first-page":"105","article-title":"Insulin-like growth factors (IGF-I, IGF-II) after gastrointestin surgery","author":"K\u00f6veker","year":"1990"},{"key":"10.1016\/j.jtct.2022.03.027_bib0022","series-title":"German childhood cancer registry - annual report 2018 (1980-2017)","author":"Kaatsch","year":"2019"},{"key":"10.1016\/j.jtct.2022.03.027_bib0023","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1055\/a-0754-2362","article-title":"Langzeitbeobachtung ehemaliger krebskranker Kinder und Jugendlicher","volume":"230","author":"Langer","year":"2018","journal-title":"Klin Padiatr"},{"key":"10.1016\/j.jtct.2022.03.027_bib0024","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","article-title":"Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients","volume":"118","author":"McDonald","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtct.2022.03.027_bib0025","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/hep.1840040121","article-title":"Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors","volume":"4","author":"McDonald","year":"1984","journal-title":"Hepatology"},{"key":"10.1016\/j.jtct.2022.03.027_bib0026","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/bmt.2017.161","article-title":"Diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in pediatric patients: a new classification from the European Society for Blood and Marrow Transplantation","volume":"53","author":"Corbacioglu","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.03.027_bib0027","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2022.03.027_bib0028","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai Acute GVHD International Consortium","volume":"22","author":"Harris","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.03.027_bib0029","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/01.PCC.0000149131.72248.E6","article-title":"International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics","volume":"6","author":"Goldstein","year":"2005","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.jtct.2022.03.027_bib0030","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1016\/S1470-2045(14)70017-8","article-title":"Fourth European Conference on Infections in Leukaemia (ECIL-4): Guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation","volume":"15","author":"Groll","year":"2014","journal-title":"Lancet Oncol"},{"issue":"suppl 1","key":"10.1016\/j.jtct.2022.03.027_bib0031","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.6004\/jnccn.2008.2001","article-title":"NCCN Task Force Report. Prevention and management of mucositis in cancer care","volume":"6","author":"Bensinger","year":"2008","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jtct.2022.03.027_bib0032","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bbmt.2005.06.001","article-title":"Blood and Marrow Transplant Clinical Trials Network Toxicity Committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation","volume":"11","author":"Ho","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.03.027_bib0033","first-page":"1610","article-title":"Serum levels of insulin-like growth factor I (IGF-I) and IGF-binding protein 3 reflect spontaneous growth hormone secretion","volume":"76","author":"Blum","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jtct.2022.03.027_bib0036","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00431-013-2059-7","article-title":"Relationship of serum insulin-like growth factor I (IGF-I) with nutritional status in pediatric patients with malignant diseases\u2014a single Romanian center experience","volume":"172","author":"Chince\u015fan","year":"2013","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jtct.2022.03.027_bib0037","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.ijrobp.2012.01.049","article-title":"Predicting the probability of abnormal stimulated growth hormone response in children after radiotherapy for brain tumors","volume":"84","author":"Hua","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jtct.2022.03.027_bib0038","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1089\/gtmb.2012.0039","article-title":"Insulin-like growth factor system in Egyptian children with acute lymphoblastic leukemia","volume":"16","author":"Zakhary","year":"2012","journal-title":"Genet Test Mol Biomarkers"},{"key":"10.1016\/j.jtct.2022.03.027_bib0039","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1203\/00006450-199903000-00015","article-title":"Monthly measurements of insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in healthy prepubertal children: characterization and relationship with growth: the 1-year growth study","volume":"45","author":"Gelander","year":"1999","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jtct.2022.03.027_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204914","article-title":"Early and late complications following hematopoietic stem cell transplantation in pediatric patients\u2014a retrospective analysis over 11 years","volume":"13","author":"Hierlmeier","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jtct.2022.03.027_bib0041","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.3389\/fimmu.2020.01646","article-title":"Insulin-like growth factor gene polymorphisms predict clinical course in allogeneic hematopoietic stem cell transplantation","volume":"11","author":"Ebbesen","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2022.03.027_bib0042","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/bmt.2017.43","article-title":"Associations between levels of insulin-like growth factor 1 and sinusoidal obstruction syndrome after allogeneic haematopoietic stem cell transplantation","volume":"52","author":"Weischendorff","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.03.027_bib0043","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/s41409-020-01127-3","article-title":"Insulin-like growth factor-I predicts sinusoidal obstruction syndrome following pediatric hematopoietic stem cell transplantation","volume":"56","author":"Ebbesen","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.03.027_bib0044","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1210\/jc.2008-0646","article-title":"Low-plasma insulin-like growth factor-I levels are associated with impaired endothelium-dependent vasodilatation in a cohort of untreated, hypertensive Caucasian subjects","volume":"93","author":"Perticone","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jtct.2022.03.027_bib0045","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1053\/j.ajkd.2010.06.006","article-title":"The role of endothelial cell injury in thrombotic microangiopathy","volume":"56","author":"Goldberg","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jtct.2022.03.027_bib0046","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.tem.2009.12.005","article-title":"IGF-1, oxidative stress and atheroprotection","volume":"21","author":"Higashi","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jtct.2022.03.027_bib0047","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1161\/01.CIR.0000144309.87183.FB","article-title":"Insulin-like growth factor-1 as a vascular protective factor","volume":"110","author":"Conti","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jtct.2022.03.027_bib0048","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JME-14-0215","article-title":"Endothelial cells and the IGF system","volume":"54","author":"Bach","year":"2015","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.jtct.2022.03.027_bib0049","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/bmt.2015.52","article-title":"Sinusoidal obstruction syndrome\/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT)","volume":"50","author":"Mohty","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.03.027_bib0050","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0168-8278(02)00049-1","article-title":"Regulation of the growth hormone receptor\/binding protein, insulin-like growth factor ternary complex system in human cirrhosis","volume":"36","author":"Donaghy","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.jtct.2022.03.027_bib0051","doi-asserted-by":"crossref","first-page":"252","DOI":"10.6002\/ect.2011.0095","article-title":"Serum insulin-like growth factor-1 and its binding protein-3 levels in children with cirrhosis waiting for a liver transplant","volume":"10","author":"Dehghani","year":"2012","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.jtct.2022.03.027_bib0052","first-page":"105","article-title":"Insulin-like growth factors and insulin-like growth factor binding proteins in adult patients with severe liver disease before and after orthotopic liver transplantation","volume":"57","author":"Weber","year":"2002","journal-title":"Horm Res"},{"key":"10.1016\/j.jtct.2022.03.027_bib0053","first-page":"762","article-title":"The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins","volume":"75","author":"Counts","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jtct.2022.03.027_bib0054","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1651-2227.1980.tb07026.x","article-title":"Somatomedin activity and growth hormone secretion. I. Changes related to body weight in anorexia nervosa","volume":"69","author":"Rappaport","year":"1980","journal-title":"Acta Paediatr Scand"},{"key":"10.1016\/j.jtct.2022.03.027_bib0055","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/17474124.2017.1370372","article-title":"Defibrotide for children and adults with hepatic veno-occlusive disease post hematopoietic cell transplantation","volume":"11","author":"Corbacioglu","year":"2017","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jtct.2022.03.027_bib0056","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/bmt.2016.351","article-title":"Use of defibrotide to treat transplant-associated thrombotic microangiopathy: a retrospective study of the Paediatric Diseases and Inborn Errors Working Parties of the European Society of Blood and Marrow Transplantation","volume":"52","author":"Yeates","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.03.027_bib0057","first-page":"e28677","article-title":"Defibrotide treatment but not prophylaxis is useful in hepatic sinusoidal obstruction syndrome in children undergoing autologous stem cell transplant following high-dose chemotherapy: a single-center experience from the Royal Marsden Hospital, UK","author":"Roy Moulik","year":"202067","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2022.03.027_bib0058","doi-asserted-by":"crossref","first-page":"8031","DOI":"10.1111\/jcmm.15434","article-title":"Defibrotide inhibits donor leucocyte-endothelial interactions and protects against acute graft-versus-host disease","volume":"24","author":"Garc\u00eda-Bernal","year":"2020","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jtct.2022.03.027_bib0059","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.bbmt.2017.03.022","article-title":"Cost-effectiveness of defibrotide in the prophylaxis of veno-occlusive disease after pediatric allogeneic stem cell transplantation","volume":"23","author":"Pichler","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.03.027_bib0060","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(11)61938-7","article-title":"Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial","volume":"379","author":"Corbacioglu","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jtct.2022.03.027_bib0061","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.bbmt.2018.02.015","article-title":"Defibrotide for sinusoidal obstruction syndrome\/veno-occlusive disease prophylaxis in high-risk adult patients: a single-center experience study","volume":"24","author":"Picod","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.03.027_bib0062","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3389\/fped.2019.00133","article-title":"Transplant-associated thrombotic microangiopathy in pediatric hematopoietic cell transplant recipients: a practical approach to diagnosis and management","volume":"7","author":"Dvorak","year":"2019","journal-title":"Front Pediatr"},{"issue":"suppl 1","key":"10.1016\/j.jtct.2022.03.027_bib0063","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2020-140475","article-title":"A pilot trial of pre-transplant risk stratification and prophylactic defibrotide to prevent serious thrombotic microangiopathy in high-risk pediatric hematopoietic stem cell transplant patients","volume":"136","author":"Higham","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.03.027_bib0064","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2813737","article-title":"Mannose-binding lectin: a potential therapeutic candidate against Candida infection","volume":"2018","author":"Hammad","year":"2018","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jtct.2022.03.027_bib0065","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/mi.2015.100","article-title":"Role of mannose-binding lectin in intestinal homeostasis and fungal elimination","volume":"9","author":"Choteau","year":"2016","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jtct.2022.03.027_bib0066","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/bmt.2016.92","article-title":"Association of mannose-binding lectin levels and invasive fungal disease in hematologic malignancy patients receiving myelosuppressive chemotherapy or allogeneic hematopoietic stem cell transplantation","volume":"51","author":"Riwes","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.03.027_bib0067","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2249.2006.03101.x","article-title":"Hormonal regulation of mannan-binding lectin synthesis in hepatocytes","volume":"145","author":"S\u00f8rensen","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jtct.2022.03.027_bib0068","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1210\/jcem.86.11.8009","article-title":"GH strongly affects serum concentrations of mannan-binding lectin: evidence for a new IGF-I independent immunomodulatory effect of GH","volume":"86","author":"Hansen","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jtct.2022.03.027_bib0069","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1210\/er.2006-0001","article-title":"The role of the IGF system in cancer growth and metastasis: overview and recent insights","volume":"28","author":"Samani","year":"2007","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jtct.2022.03.027_bib0070","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.mrrev.2016.08.007","article-title":"Insulin-like growth factor (IGF) axis in cancerogenesis","volume":"772","author":"Kasprzak","year":"2017","journal-title":"Mutat Res Rev Mutat Res"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722011952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722011952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T23:47:55Z","timestamp":1726444075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636722011952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":68,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S2666636722011952"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2022.03.027","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Serum Insulin-Like Growth Factor 1 on Hematopoietic Stem Cell Transplantation Outcome in Pediatric Cancer Patients","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2022.03.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}